hormone receptor status
DNA methylation and hormone receptor status in breast cancer
... There are at least two other alternative explanations for the observed associations of gene DNA methylation with hormone receptor status in our study. First, specific methylation patterns may arise ...
10
Risk of contralateral second primary breast cancer according to hormone receptor status in Germany
... HR status registration was too low for a meaningful data analysis until 1998 because German cancer registries do not rou- tinely collect or receive data of hormone receptor ...HR status ...
7
Hormone receptor status predicts the clinical outcome of human epidermal growth factor 2-positive metastatic breast cancer patients receiving trastuzumab therapy: a multicenter retrospective study
... HR status on trastuzumab treatment benefits in advanced HER2-positive breast cancer are ...HR status on the clinical outcome of trastuzumab therapy for Chinese MBC ...
12
Correlation between CpG methylation profiles and hormone receptor status in breast cancers
... to hormone regulation, but the correlation is not clear ...global hormone-specific DNA methylation ...HR status between clusters of DNA methylation ...ER status was positively associated with ...
13
Study of epidemiological aspects and hormone receptor status of meningiomas
... of hormone receptors in the pathogenesis of meningioma, thus clearly indicating the biased attitude of the tumour towards the females as compared to the ...
5
Prospective study of correlation of pathological response and hormone receptor status after neoadjuvant chemotherapy in carcinoma breast and quantification of hormone receptor status for chemotheraphy dose adjustment
... 12.GG Steger , R Greil, R Jakesz , etal: A randomized phase III study comparing epirubicin, docetaxel and capecitabine EDC to epirubicin and docetaxel ED as neoadjuvant treatment for ear[r] ...
109
Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status
... Preclinical studies have shown that AR inhibits ER activity by blocking it’s downstream transcription targets, thus inhibiting ER-stimulated tumor growth in ER-positive cell lines [3, 20]. The proposed mechanism is that ...
9
Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients
... Treating hormone receptor-positive tumors with hormonal therapies has been shown to be a contributing factor in better survival among women with breast cancer ...
10
Vol 27, No 3 (2014)
... with hormone receptor status information, 49% (584) were both ER- and PR-positive, 15% (172) were ER- positive and PR-negative, 3% (34) were ER-negative and PR-positive, and 17% (199) were ER- and ...
7
Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trials
... compare the distribution of baseline characteristics among groups. Endpoints studied were overall survival and distant metastasis free survival. Overall survival time was defined as the time between randomization and ...
11
Analysis of cyclins A, B1, D1 and E in breast cancer in relation to tumour grade and other prognostic factors
... hormone receptor status and a positive correlation with triple negative breast carcinomas associating cyclin E expression with unfavourable ...
8
Journal of Cancer Research and Treatment
... disease status was done in the patients who were part of the study ...node status for metastasis, procedure followed for biopsy, hormone receptor status, histopathological grading, TNM ...
6
Plasma VEGF as a Marker of Therapy in Breast Cancer Patients.
... Results: There was a significant (P<0.001) increase in plasma VEGF level in breast cancer patients (Mean± SD 136.22±9.95) compared with controls(61.88±6.19). Our study showed that increased plasma VEGF levels were ...
7
PubMedCentral-PMC5363272.pdf
... Additionally, in disease-specific examinations, patients with less lymph node involvement and ER positive tumors also had less breast cancer mortality. Patients who had non- randomized, clinically administered adjuvant ...
13
Impact of tumor biomarkers and patient’s age on the “disease stage” in women with breast cancer in Erbil city
... factor receptor-2and hormone receptor status on the stage of breast cancer at the time of presentation, and secondly, to assess the role of “women’s age” on the level of biomarker expressions ...
10
Material and Methods: 50 breast cancer patients who attended the department of general surgery, king
... Following the evaluation, the diagnosis was confirmed, and patients were operated, and specimens sent for histopathological examination and assessment of hormone receptor status. The information ...
5
HER2-positive breast cancer patients receiving trastuzumab treatment obtain prognosis comparable with that of HER2-negative breast cancer patients
... node status, hormone receptor status, surgery type, radiotherapy, endocrine therapy, and chemo- therapy (Table ...HER2 status or by different treatments were predictive for 3-DFS, and t ...
7
A clinician’s guide to understanding resistance to thyroid hormone due to receptor mutations in the TRα and TRβ isoforms
... nuclear receptor (NR) family that in- cludes the steroid hormone, vitamin D, peroxisome pro- liferator activator, and retinoic acid ...to hormone, they have the ability to bind to hormone ...
11
Key words
... tification early noninvasive cancers and allow for proper therapy before they become invasive, or in recognizing invasive cancers at an early treat- able phase. However, screening does not prevent cancer. Breast cancer ...
9
An intronic SNP in the thyroid hormone receptor β gene is associated with pituitary cell specific over expression of a mutant thyroid hormone receptor β2 (R338W) in the index case of pituitary selective resistance to thyroid hormone
... Background: The syndrome of resistance to thyroid hormone (RTH) is caused by mutations in the thyroid hormone receptor b gene ( THRB ). The syndrome varies from asymptomatic to diffuse ...
7